Per the terms of the agreement, Sobi is expected to pay upwards of $950 million upfront in cash to acquire Arthrosi.The deal ...

Expands Sobi’s pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi’s mid- to long-term growth and margin trajectory Sobi® (STO:SOBI) has ...

Discover why Mirum Pharmaceuticals, Inc. stock surged 65%. Explore robust pipeline growth, revenue outlook, and analyst ...

ICL Group strikes a two-stage deal to buy Bartek Ingredients, adding food-grade acidulants and boosting its specialty food solutions platform.

Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF)(the 'Company” or 'Goliath”) is pleased to report longtime ...

Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with ...

Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectorySTOCKHOLM, Dec.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a ...

Detailed price information for Max Resource Corp (MAX-X) from The Globe and Mail including charting and trades.

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here’s the roundup for Wednesday, December 17, 2025.

Industry consolidation and sustainability drive major changes as recycling challenges mount across global markets ...

Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment----PROBE will leverage data from over 70 million ...